Afuco™ Anti-Human TLR4 ADCC Therapeutic Antibody (NI-0101), ADCC Enhanced
Anti-TLR4 ADCC Enhanced Antibody (NI-0101) is an ADCC enhanced antibody produced by our Afuco™ platform. NI-0101 is an anti-Toll-like Receptor 4 (TLR4) monoclonal antibody that can be used in various chronic inflammatory diseases including, arthritis, atherosclerosis, asthma, lupus, osteoporosis, transplant rejection, and contact dermatitis.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-591CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | TLR4 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Applications | FuncS |
| Storage | Short term: store at 4°C (over 6 months), long term: -20°C or -80°C. |